The CU Center for Rare Melanomas is a joint clinical and research center dedicated to the understanding and treatment of rare,non-sum related types of melanoma such as mucosal, acral, and uveal. Our mission is to uncover causes and improve prevention, diagnosis, and treatment of rare melanomas through cutting-edge basic, epidemiologic and translational research, initiation of clinical trials designed for patients with rare melanomas and increasing awareness of rare melanomas in the medical community and general public.
Bemis, L.T., Chen,R., Amato,C.M., Robinson,S.E., Classen,E.H., Coffey,D.G., Erickson,P.F. and Robinson,W.A. microRNA-137 Targets Microphthalmia-associated Transcription Factor (MITF) Expression in Melanoma Cell Lines. Cancer Res. 2008;68(5):1362-8. PMID 18316599
Swick BL, Ravdel L, Fitzpatrick JE, Robinson WA. Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate. J Cutan Pathol. 2008 Feb;35(2):197-202. PMID 18190445
Swick BL, Ravdel L, Fitzpatrick JE, Robinson WA Merkel cell carcinoma: Evaluation of KIT expression. J of Cutaneous Path 34:324-27. 2007. PMID 17381803
High WA, Robinson WA.Genetic mutations involved in melanoma: a summary of our current understanding. Adv Dermatol.;23:61-79. 2007. PMID 18159896
Lewis KD, Robinson WA, Millward MJ, et al A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma. Invest New Drugs. 2007.PMID 17891338
Bemis LT, Robinson WA, McFarlane R, et al. EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome. Lancet Oncol.;8:559-60. 2007. PMID 17540308